Implementing the Stockholm Conference hierarchy of objective quality criteria in a routine laboratory

被引:17
作者
Dhatt, Gurdeep S.
Agarwal, Mukesh M.
Bishawi, Bassarn
Gill, Janice
机构
[1] Tawam Hosp, Dept Pathol & Lab Med, Al Ain, U Arab Emirates
[2] UAE Univ, Dept Pathol, Fac Med, Al Ain, U Arab Emirates
[3] RCPA Qual Assurance Programs Pty Ltd, Flinders Med Ctr, Bedford Pk, SA, Australia
关键词
biological variation; imprecision; objective; quality; specifications;
D O I
10.1515/CCLM.2007.105
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Analytical performance of clinical laboratory testing should be evaluated against objective quality specifications. The Stockholm Conference consensus recommendation states that from a hierarchy of quality models, the highest-ranking model should be used. This study reports the performance of a routine clinical laboratory using these quality recommendations. Quality standards recommended for use in manufacturers' package inserts are also compared against the objective criteria. Methods: Imprecision of 22 analytes was monitored by analyzing three levels of commercial quality control (QC) material daily over a 6-month period. The performance for each analyte was evaluated against defined quality specifications based on biological variation and the National Cholesterol Education Panel (NCEP) criteria. Results: Overall, objective quality specifications were met by the laboratory for 18/22 (82%) analytes. e performance for analytes not meeting the criteria was assessed against quality targets based on a model lower in the hierarchy, i.e., interlaboratory imprecision data derived from an accredited EQA program. All analytes met these quality targets. When quality targets set by the manufacturer were applied to biological variation and NCEP criteria, results for only 8/22 (36%) analytes met the targets. Conclusions: Objective quality specifications can be consistently achieved in a routine laboratory. The hierarchy model of the Stockholm Conference should be promoted for global adoption.
引用
收藏
页码:549 / 552
页数:4
相关论文
共 14 条
[1]  
[Anonymous], BIOL VARIATION DATAB
[2]  
[Anonymous], 17511 ISO
[3]  
BARNETT RN, 1968, AM J CLIN PATHOL, V50, P671
[4]  
COTLOVE E, 1970, CLIN CHEM, V16, P1028
[5]   Test result variation and the quality of evidence-based clinical guidelines [J].
Fraser, CG .
CLINICA CHIMICA ACTA, 2004, 346 (01) :19-24
[6]   Proposals for setting generally applicable quality goals solely based on biology [J].
Fraser, CG ;
Petersen, PH ;
Libeer, JC ;
Ricos, C .
ANNALS OF CLINICAL BIOCHEMISTRY, 1997, 34 :8-12
[7]  
JACKSON CM, 2006, IVD TECHNOLOGY, V24
[8]   The Stockholm Consensus Conference on Quality Specifications in Laboratory Medicine, 25-26 April 1999 - Foreword [J].
Kallner, A ;
McQueen, M ;
Heuck, C .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1999, 59 (07) :475-476
[9]  
Kenny D, 1999, SCAND J CLIN LAB INV, V59, P585
[10]  
*MED LAB, 2003, 15189 ISO MED LAB